Oppenheimer Asset Management Inc. acquired a new position in shares of Ventas, Inc. (NYSE:VTR – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 7,859 shares of the real estate investment trust’s stock, valued at approximately $698,000.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Family Wealth Partners LLC increased its position in Ventas by 5.6% in the 2nd quarter. Family Wealth Partners LLC now owns 10,034 shares of the real estate investment trust’s stock valued at $891,000 after acquiring an additional 529 shares during the period. Tema ETFs LLC boosted its position in Ventas by 10.5% during the 2nd quarter. Tema ETFs LLC now owns 9,169 shares of the real estate investment trust’s stock worth $814,000 after acquiring an additional 870 shares during the period. E. Ohman J or Asset Management AB grew its stake in shares of Ventas by 12.1% in the second quarter. E. Ohman J or Asset Management AB now owns 17,564 shares of the real estate investment trust’s stock worth $1,560,000 after purchasing an additional 1,900 shares in the last quarter. Handelsbanken Fonder AB increased its holdings in shares of Ventas by 12.8% during the second quarter. Handelsbanken Fonder AB now owns 276,474 shares of the real estate investment trust’s stock valued at $24,551,000 after purchasing an additional 31,380 shares during the period. Finally, Shrier Wealth Management LLC increased its holdings in shares of Ventas by 0.8% during the second quarter. Shrier Wealth Management LLC now owns 27,876 shares of the real estate investment trust’s stock valued at $2,475,000 after purchasing an additional 227 shares during the period. 94.18% of the stock is owned by institutional investors.
Ventas Trading Down 0.4%
Shares of VTR stock opened at $91.18 on Tuesday. The stock has a 50-day simple moving average of $90.68 and a 200 day simple moving average of $86.72. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The stock has a market capitalization of $46.77 billion, a P/E ratio of 168.85, a P/E/G ratio of 2.11 and a beta of 0.69. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.
Analyst Ratings Changes
VTR has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Ventas in a report on Tuesday, June 16th. Raymond James Financial assumed coverage on shares of Ventas in a research report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price target on the stock. Royal Bank Of Canada upped their price target on shares of Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a research note on Friday. Scotiabank decreased their price objective on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Finally, Barclays assumed coverage on shares of Ventas in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price objective on the stock. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.
Get Our Latest Analysis on Ventas
Insider Activity
In other Ventas news, Director Michael J. Embler bought 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 0.53% of the stock is owned by corporate insiders.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Stories
- Five stocks we like better than Ventas
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
